Menu

Freya Leask

Publisher, Future Science Group

Follow

About Freya Leask

I am the Editor of RegMedNet, here to help users make the most of the website. I am passionate about digital and STM publishing, as well as regenerative medicine and medical 3D printing. Please get in touch if you have any queries or comments!

Contact Freya Leask

Web

https://www.future-science-group.com/

Email

f.leask@futuremedicine.com

Phone Number

+44 (0)20 8371 6090

More About Freya Leask

Sector

Other

Areas of Interest

Stem cells: iPSCs

Job Function

Other

Intro Content

A year in RegMedNet

A year in RegMedNet

In this article, Publisher Freya Leask reflects on a year …

Spinal cord injury in brief: a round-up of the latest news

NEWS ROUND-UP

News & views, Research

Spinal cord injury in brief: a round-up of the latest news

Aug 08, 2018

Engineered peptide hydrogels now available from Manchester BIOGEL

Engineered peptide hydrogels now available from Manchester BIOGEL

Jun 19, 2018

Placing the Cell and Gene Therapy Catapult at the forefront of translational research: an interview with Jonathan Appleby

Member Exclusive

Cell therapy, Industry developments

Placing the Cell and Gene Therapy Catapult at the forefront of translational research: an interview with Jonathan Appleby

Jun 18, 2018

Diabetes in brief: a round-up of the latest news

NEWS ROUND-UP

News & views, Research

Diabetes in brief: a round-up of the latest news

Jun 12, 2018

Fujifilm completes acquisition of Irvine Scientific

Member Exclusive

Cell therapy, Industry developments

Fujifilm completes acquisition of Irvine Scientific

Jun 05, 2018

Cell and Gene Therapy Catapult opens new manufacturing center to accelerate UK industry

Member Exclusive

Cell therapy, Industry developments, Manufacturing

Cell and Gene Therapy Catapult opens new manufacturing center to accelerate UK industry

Apr 23, 2018

First patients treated for Alzheimer’s disease at Japanese clinic

Member Exclusive

First patients treated for Alzheimer’s disease at Japanese clinic

Apr 16, 2018

Cell reprogramming roadblock understood 12 years after discovery of iPSCs

Member Exclusive

News & views, Research

Cell reprogramming roadblock understood 12 years after discovery of iPSCs

Apr 13, 2018

First allogeneic stem cell therapy approved for use in EU

News & views, Cell therapy, Clinical trials

First allogeneic stem cell therapy approved for use in EU

Mar 27, 2018

UK patients regain sight after receiving hESC-derived RPE tissue

News & views, Cell therapy, Clinical trials

UK patients regain sight after receiving hESC-derived RPE tissue

Mar 20, 2018

New paper from FDA commissioner lays roadmap for regulating "modern products" with "traditional tools"

Member Exclusive

Cell therapy, Ethics & policy, Industry developments

New paper from FDA commissioner lays roadmap for regulating "modern products" with "traditional tools"

Mar 13, 2018

Advanced Therapies Treatment Centers will increase UK patient access to advanced therapies

News & views, Cell therapy, Industry developments

Advanced Therapies Treatment Centers will increase UK patient access to advanced therapies

Mar 12, 2018

RegMedNet posts: the gender balance

LONGER READ

RegMedNet posts: the gender balance

Mar 05, 2018

New research demonstrates donor age strongly influences survival after stem cell transplant

News & views, Research

New research demonstrates donor age strongly influences survival after stem cell transplant

Feb 26, 2018

New collaboration will develop and deliver novel ulcerative colitis treatment

New collaboration will develop and deliver novel ulcerative colitis treatment

Feb 23, 2018

First serious adverse reaction to iPSC-derived retinal cells reported

News & views, Cell therapy, Spotlight on iPSC production

First serious adverse reaction to iPSC-derived retinal cells reported

Jan 17, 2018

World Stem Cell Summit will honor leaders in regenerative medicine, connect international experts

World Stem Cell Summit will honor leaders in regenerative medicine, connect international experts

Jan 15, 2018

Final draft guidelines from NICE recommend gene therapy for rare immune deficiency

Spotlight on immunotherapy, Ethics & policy, Industry developments

Final draft guidelines from NICE recommend gene therapy for rare immune deficiency

Jan 05, 2018

Diabetes drug fights memory loss in mice with Alzheimer’s

Member Exclusive

Diabetes drug fights memory loss in mice with Alzheimer’s

Jan 03, 2018

A year in RegMedNet

Member Exclusive LONGER READ

RegMedNet, Regenerative Medicine

A year in RegMedNet

Jan 02, 2018

RegMedNet at the 5th Annual European Advanced Therapies Investor Day

LONGER READ

News & views, Spotlight on immunotherapy, Spotlight on commercialization and translation, Events

RegMedNet at the 5th Annual European Advanced Therapies Investor Day

Nov 21, 2017

Circadian rhythm affects wound healing, daytime injuries heal faster

News & views, Research, Spotlight on wound healing

Circadian rhythm affects wound healing, daytime injuries heal faster

Nov 08, 2017

New funding will support development of personalized cell therapies for compromised patient populations

Member Exclusive

News & views, Spotlight on commercialization and translation, Cell therapy

New funding will support development of personalized cell therapies for compromised patient populations

Oct 10, 2017

Cell and Gene Therapy Catapult enters into partnership with Forum for Innovative Regenerative Medicine

Member Exclusive

News & views, Spotlight on commercialization and translation, Industry developments

Cell and Gene Therapy Catapult enters into partnership with Forum for Innovative Regenerative Medicine

Oct 06, 2017

First functionally vascularized lung scaffold developed

First functionally vascularized lung scaffold developed

Sep 07, 2017